What can be expected from the ophthalmic devices market? Which areas are going to grow at the fastest rates? Visiongain’s brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.
Our 205-page report provides 176 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions.
Forecasts from 2015-2025 and other analyses show you commercial prospects Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and Porter’s Five Forces analysis), product profiles and commercial developments. Read the full transcripts of two exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales, including: • Ellie Bai, Press Relations Officer, Taiwan Liposome Company • Martina Iniotri, Ophthalmic Specialist, JINS Eyewear Inc.
See revenue forecasts for the leading international markets How will leading national markets perform to 2025? Our study forecasts ophthalmic device revenues in national markets, including: • US • Japan • China • Russia • Germany • France • Spain • UK • Italy • Rest of Europe • Brazil • Mexico • India • Rest of the World
Leading companies and potential for market growth Overall world revenue for ophthalmic devices market will reach $18bn in 2015, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the world’s largest markets will combine with a shift towards newer and more expensive lenses which will drive sales to 2025.
Our work analyses the key companies in the market. See Visiongain’s analysis of 10 leading ophthalmic device companies, including these: • Johnson and Johnson • Alcon (Novartis) • Coopervision • Bausch and Lomb (Valeant) • Abbot Medical • Hoya Corporation • Topcon • Carl Zeiss Meditec • Nidek Co. • STAAR Surgical
A company profile gives you the following information where available: • Historical revenues from 2013 to 2014 • Discussion of a company’s activities and outlook • Recent financial results • Assessment of recent developments – mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
Research and development – assess innovation, trends and possibilities What about R&D – the pipeline for new devices? You see trends for these areas and technologies: • Smart Lens technology • Ocular drug delivery devices • Highly efficient surgical devices and suites
The R&D pipeline for surgical devices is particularly strong, with faster and more precise machines being in demand. These are not revolutions in the technology and may not allow for new surgeries to be performed, but instead increase the efficiency of current surgeries.
What issues will affect the ophthalmic devices industry? Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses: • Highly challenging payment environment • Rapidly advancing technology leading to quickly eroding profit margins • The rise of pharmaceutical treatments for a number of ophthalmic diseases
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices report helps you In summary, our 205-page report gives you the following knowledge: • Revenue forecasts to 2025 for the global ophthalmic devices market – discover the industry’s prospects, finding promising places for investments and revenues • Revenue forecasts to 2025 for the leading regional ophthalmic device markets – US, Japan, China, Russia, UK, Germany, Italy, Spain, France, Rest of Europe, Brazil, India, Mexico, South Korea and Rest of the World • Predicted revenues of the leading national markets for contact lenses to 2025 – see potentials of top products • Assessment of 11 leading companies – hear about products, results and strategies including pipeline analysis and recent developments • Review of R&D pipelines – investigate developmental trends and progress • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market • View opinions from our survey, seeing interviews with authorities
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the ophthalmic devices market and leading companies. You find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Ophthalmic Devices Market Overview 1.2 Why You Should Buy This Report 1.3 How This Report Delivers 1.4 Key Questions Answered by This Analytical Report 1.5 Who is This Report For? 1.6 Methodology 1.7 Frequently Asked Questions (FAQs) 1.8 Associated Reports 1.9 About Visiongain
2. Introduction to the Ophthalmic Devices Market 2.1 The Eye: An Overview of Its Structure and Function 2.2 The Global Burden of Eye Disease 2.3 The Diagnosis and Surgical Treatment for Eye Diseases 2.3.1 Refractive Errors (Myopia, Hyperopia or Astigmatism) 2.3.1.1 LASIK Eye Surgery (Laser In-Situ Keratomileusis) 2.3.1.2 Phakic Intraocular Surgery 2.3.1.3 Photorefractive Keratectomy (PRK) 2.3.1.4 Conductive Keratoplasty (CK) 2.3.1.5 Refractive Lens Exchange (RLE) 2.3.2 Cataracts 2.3.2.1 Phacoemulsification and Intraocular Lenses 2.3.2.2 Microincision Cataract Surgery (MICS) 2.3.3 Glaucoma 2.3.3.1 Diagnosis of Glaucoma 2.3.3.2 Glaucoma Surgical Treatment 2.3.4 Age-Related Macular Degeneration (AMD) 2.3.4.1 Dry (non-exudative) AMD 2.3.4.1.1 Treatment for Dry AMD 2.3.4.2 Wet (exudative) AMD 2.3.4.3 Surgical Treatment of Wet AMD 2.3.4.3.1 Photodynamic Therapy 2.3.4.3.2 Laser Photocoagulation 2.3.4.3.3 Radtiotherapy – Oraya Therapy 2.3.4.3.4 Newer Types of Surgery 2.3.4.3.5 Wet AMD: Poor Outcomes with Surgical Procedures 2.3.5 Diabetic Retinopathy (DR) 2.3.5.1 Diagnosis of Diabetic Retinopathy 2.3.5.2 Treatment of Diabetic Retinopathy 2.3.6 Dry Eye Syndrome (DES) 2.3.6.1 Treatment of DES 2.3.6.1.1 Punctal Occlusion 2.3.6.1.2 Salivary Gland Autotransplantation 2.3.6.1.3 Tarsorrphaphy 2.4 Ophthalmic Devices 2.4.1 What are Ophthalmic Devices? 2.4.2 Devices: Classification 2.4.2.1 The US Medical Devices Classification System 2.4.2.2 The EU Medical Devices Classification System 2.4.2.3 The Japanese Medical Devices Classification System 2.4.3 Regulation of Ophthalmic Devices 2.4.3.1 The US Approval and Regulation System 2.4.3.2 The EU Approval and Regulation System 2.4.3.3 The Japanese Approval ad Regulation System 2.5 Ophthalmic Devices: Market Segmentation 2.5.1 The Monitoring and Diagnostics Ophthalmic Devices Market 2.5.1.1 General Eye Health 2.5.1.2 Refractive Monitoring and Diagnostic Devices 2.5.1.3 Glaucoma Monitoring and Diagnostic Devices 2.5.2 The Surgical Ophthalmic Devices Market 2.5.2.1 Cataract Surgery Devices 2.5.2.2 Glaucoma Surgery Devices 2.5.2.3 Refractive Error Surgery Devices 2.5.2.4 Vitreoretinal Surgery Devices 2.5.3 The Vision Care Devices Market
3. The Global Ophthalmic Devices Market 2015-2025 3.1 The Medical Devices Market Overview 3.1.1 The Global Medical Devices Market, 2015-2025 3.2 The Ophthalmic Devices Market by Submarket, 2014 3.3 The Ophthalmic Devices Market, 2015-2025
4. The Ophthalmic Vision Care Devices Market, 2015-2025 4.1 The Ophthalmic Vision Care Devices Market Overview 4.2 The Ophthalmic Vision Care Devices Market, 2015-2025 4.2.1 The Ophthalmic Vision Care Devices Market by Segment 4.2.1.1 The Ophthalmic Vision Care Devices Market by Segment, 2014 4.2.1.2 The Ophthalmic Vision Care Devices Market by Segment, 2015-2025 4.2.1.2.1 The Daily Disposable Contact Lens Market, 2015-2025 4.2.1.2.2 The Others Contact Lenses Market, 2015-2025 4.3 The Leading National Vision Care Market Forecast, 2015-2025 4.3.1 The Leading National Vision Care Markets, 2014 4.3.2 The Leading National Vision Care Market Forecast, 2015-2025 4.3.2.1 The US Vision Care Market Forecast, 2015-2025 4.3.2.2 The EU Vision Care Market Forecast, 2015-2025 4.3.2.3 The Chinese Vision Care Market Forecast, 2015-2025 4.3.2.4 The Japanese Vision Care Market Forecast, 2015-2025 4.3.2.5 The Russian Vision Care Market Forecast, 2015-2025 4.3.2.6 The Brazilian Vision Care Market Forecast, 2015-2025 4.3.2.7 The Indian Vision Care Market Forecast, 2015-2025 4.3.2.8 The South Korean Vision Care Market Forecast, 2015-2025 4.3.2.9 The Mexican Vision Care Market Forecast, 2015-2025 4.3.2.10 The Rest of the World Vision Care Market Forecast, 2015-2025 4.4 Contact Lenses on the Market 4.5 The Contact Lens Market: New Product Development and Product Pipeline 4.5.1 1-DAY ACUVUE MOIST Multifocal Lenses (Johnson & Johnson Vision Care) 4.5.2 Biotrue ONEday Contact Lenses (Bausch and Lomb (Valeant)) 4.5.3 1-DAY ACUVUE DEFINE with LACERON Technology (Johnson & Johnson Vision Care) 4.5.4 Google Smart Lenses in Cooperation with Novartis 4.5.5 Sensimed (Triggerfish) 4.6 SWOT Analysis of the Vision Care Market, 2015-2025 4.6.1 Strengths 4.6.1.1 Increasing Adoption of Disposable Contact Lenses 4.6.1.2 Contact Lenses for Non-Ocular Disorders 4.6.1.3 Linked to Changes in Consumer Spending 4.6.2 Weaknesses 4.6.2.1 High Entry Barriers for New Entry Manufacturers 4.6.2.2 Fast Downward Pricing Pressure 4.6.3 Opportunities 4.6.3.1 Growing Affluent Population in Developing Economies 4.6.3.2 Increasing Access to Diagnostic Equipment 4.6.3.3 Sales of Cosmetic and Coloured Lenses 4.6.3.4 Ageing Population 4.6.4 Threats 4.6.4.1 Growing Demand for LASIK Surgery
5. The Ophthalmic Diagnostics and Monitoring Devices Market, 2015-2025 5.1 The Ophthalmic Diagnostics and Monitoring Devices Market Overview 5.2 The Ophthalmic Diagnostics and Monitoring Devices Market, 2014 5.3 The Ophthalmic Diagnostics and Monitoring Devices Market Forecast by. Segment, 2015-2025 5.3.1 The Autorefractor/Keratometer Market Froecast, 2015-2025 5.3.2 The Fundus Camera Market Forecast, 2015-2025 5.3.3 The Slit Lamp Market Forecast, 2015-2025 5.3.4 The OCT Machine Market Forecast, 2015-2025 5.3.4.1 Ophthalmic OCT Machine Products 5.3.5 The Other Ophthalmic Diagnostics and Monitoring Devices Market Forecast, 2015-2025 5.4 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices Market, 2015-2025 5.4.1 Strengths 5.4.1.1 Continuing Developing of Improved Technologies 5.4.1.2 Stable Future Revenue Through Lack of Pricing Pressure 5.4.2 Weaknesses 5.4.2.1 Shortage of Ophthalmic Device Providers 5.4.3 Opportunities 5.4.3.1 Ageing Population 5.4.3.2 Increasing Demand for Advanced Optical Coherence Tomography Machines 5.4.3.3 Increasing Demand for Advanced Ophthalmic Diagnostics 5.4.4 Threats 5.4.4.1 Increasing Cost of Healthcare
6. The Ophthalmic Surgical Devices Market Forecast, 2015-2025 6.1 The Ophthalmic Surgical Devices Market Overview 6.1.1 The Surgical Ophthalmic Devices Market, 2014 6.2 The Surgical Ophthalmic Devices Market Forecast, 2015-2025 6.2.1 The Intraocular Lenses Market Forecast, 2015-2025 6.2.1.1 Intraocular Lens Products 6.2.1.2 Intraocular Lens Product Pipeline 6.2.1.2.1 The Light Adjustable Lens (Calhoun) 6.2.1.2.2 LiquiLens IOL (Vision Solution Technologies) 6.2.1.2.3 Smart IOL (Medennium) 6.2.1.2.4 NuLens Accommodating IOL (NuLens) 6.2.1.2.5 The FluidVision Lens (PowerVision) 6.2.2 The Ophthalmic Laser Market Forecast, 2015-2025 6.2.2.1 Laser System Products 6.2.2.1.1 Refractive Lasers 6.2.2.1.1.1 STAR S4 IR Excimer Laser (Abbott Medical Optics) 6.2.2.1.1.2 iFS Advanced Femtosecond Laser (About Medical Optics) 6.2.2.1.1.3 WaveLight Allergretto Wave Eye-Q Laser (Alcon (Novartis)) 6.2.2.1.1.4 WaveLight Refractive Suit (Alcon (Novartis)) 6.2.2.1.1.5 NIDEK Advanced Vision Excimer Laser System NAVEX Quest (Nidek) 6.2.2.1.1.6 TECHNOLAS TENEO 317 Laser (Bausch and Lomb (Valeant)) 6.2.2.1.1.7 TECHNOLAS TENEO 217P Laser (Bausch and Lomb (Valeant)) 6.2.2.1.2 Cataract Lasers 6.2.2.1.2.1 The LenSx Laser (Alcon (Novartis)) 6.2.2.1.2.2 LENSAR Laser System (LENSAR) 6.2.2.1.2.3 Catalys Precision Laser System (Abbott Medical Optics) 6.2.2.1.2.4 VICTUS Femtosecond Laser Platform (Bausch and Lomb (Valeant)) 6.2.2.1.2.5 Lumenis Vision (InSight) 6.2.3 The Phacoemulsification Devices Market Forecast, 2015-2025 6.2.4 The Ophthalmic Visoelastic Devices Market Forecast, 2015-2025 6.2.5 The Other Surgical Ophthalmic Devices Market Forecast, 2015-2025 6.2.6 Ophthalmic Drug Delivery Devices 6.2.6.1 Recent Approvals 6.2.6.1.1 Retisert fluocinolone acetonide (Bausch and Lomb (Valeant)) 6.2.6.1.2 Ozurdex dexamethasone (Allergan) 6.2.6.1.3 Illuvien fluocinolone acetonide (Alimera Sciences) 6.2.6.2 Novel Ocular Drug Delivery Platform Pipeline 6.2.6.2.1 ECT Platform (Neurotech Pharamceuticals) 6.2.6.2.2 Hydrogel Technology Products (Ocular Therapeutix) 6.2.6.2.3 ProDex (Taiwan Liposome Company) 6.2.6.3 Microinvasive Glaucoma Surgery (MIGS) 6.2.6.3.1 Trabectome (NeoMedix Corporation) 6.2.6.3.2 EX-PRESS Glaucoma Filtration Devices (Alcon (Novartis)) 6.2.6.3.3 iStent (Glaukos) 6.2.6.4 Stents in the Glaucoma Pipeline 6.2.6.4.1 CyPass Micro-Stent (Transcend Medical) 6.2.6.4.2 Hydrus (Ivantis) 6.2.6.4.3 XEN Gel Stent (Aquesys) 6.3 SWOT Analysis of the Ophthalmic Surgical Devices Market, 2015-2025 6.3.1 Strengths 6.3.1.1 Highest Growing Submarket 6.3.1.2 Fast Development of IOL Technology 6.3.1.3 Increasingly Sophisticated Laser Surgery 6.3.2 Weaknesses 6.3.2.1 Challenging Reimbursement Environment 6.3.3 Opportunities 6.3.3.1 Ageing Population 6.3.3.2 Rising Diabetes Epidemic 6.3.3.3 Large Pipeline of Products 6.3.4 Threats 6.3.4.1 Pharmaceuticals Compete as Therapies for Ocular Diseases
7. The Leading National Ophthalmic Devices Markets, 2015-2025 7.1 The Leading National Ophthalmic Devices Markets, 2014 7.2 The Leading National Ophthalmic Devices Markets, 2025 7.2.1 The US Ophthalmic Devices Market Forecast, 2015-2025 7.2.2 The European Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.1 The European Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.2 The German Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.3 The French Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.4 The Italian Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.5 The Spanish Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.6 The UK Ophthalmic Devices Market Forecast, 2015-2025 7.2.2.7 The Rest of Europe Ophthalmic Devices Market Forecast, 2015-2025 7.2.3 The Japanese Ophthalmic Devices Market Forecast, 2015-2025 7.2.4 The Brazilian Ophthalmic Devices Market Forecast, 2015-2025 7.2.5 The Russian Ophthalmic Devices Market Forecast, 2015-2025 7.2.6 The Indian Ophthalmic Devices Market Forecast, 2015-2025 7.2.7 The Chinese Ophthalmic Devices Market Forecast, 2015-2025 7.2.8 The South Korean Ophthalmic Devices Market Forecast, 2015-2025 7.2.9 The Mexican Ophthalmic Devices Market Forecast, 2015-2025
8. The Leading Ophthalmic Devices Companies 2015 8.1 Alcon (Acquired by Novartis) 8.1.1 Alcon Financial Performance, 2013-2014 8.1.1.1 Surgical Segment: Financial Performance, 2013-2014 8.1.1.2 Vision Care Segment: Financial Performance, 2013-2014 8.1.2 Product Line 8.1.2.1 Surgical Products 8.1.2.1.1 CENTURION Vision System 8.1.2.1.2 LenSx Laser 8.1.2.1.3 WaveLight Refractive Suite 8.1.2.1.4 WaveLight Allegretto Wave Eye-Q Laser 8.1.2.1.5 ACRYSOF IOLs 8.1.2.1.6 EX-PRESS Glaucoma Filtration Device 8.1.2.1.7 INFINITI Vision System 8.1.2.2 Vision Care Products 8.1.2.2.1 AIR OPTIX 8.1.2.2.2 FOCUS DAILIES 8.1.2.2.3 FreshLook Colour Lenses 8.1.3 Mergers and Acquisitions 8.1.3.1 Acquisition of Alcon 8.1.3.2 Acquisition of Endure Medical Systems 8.1.3.3 Acquisition of SensoMotoric Instruments GmbH (SMI) – Ophthalmic Division 8.1.3.4 Acquisition of LexSx Lasers 8.1.3.5 Job Losses 8.1.3.6 Acquisition of WaveTec Vision 8.1.3.7 Licensing of Google [X] Smart Lens Technology 8.2 Abbott Medical Optics (AMO) 8.2.1 AMO Financial Performance, 2013-2014 8.2.2 AMO Product Portfolio 8.2.3 Mergers and Acquisitions 8.2.3.1 Abbotts Acquisition of Advanced Medical Optics 8.2.3.2 Acquisition of OptiMedica 8.2.3.3 Acquisition of VISX 8.3 Bausch and Lomb (B&L) (Acquired by Valeant) 8.3.1 Bausch and Lomb Financial Performance, 2013-2014 8.3.2 Product Line 8.3.2.1 Surgical Products 8.3.2.1.1 Vitreoretinal Products 8.3.2.1.1.1 Retisert (fluocinolone acetonide intravitreal implant) 0.59g 8.3.2.1.2 Cataracts and Lens Products 8.3.2.1.2.1 enVista Intraocular Lens (IOL) 8.3.2.1.2.2 TRULIGN Toric IOL 8.3.2.1.2.3 Akreos Advanced Optics (AO) and MICS Lens 8.3.2.1.2.4 Crystalens AO Lens 8.3.2.1.2.5 SofPort AO Aspheric Lens 8.3.2.1.3 Cataracts Surgery Products 8.3.2.1.3.1 Stellaris Vision Enhancement System 8.3.2.1.3.2 VICTUS Femtosecond Laser Platform 8.3.3 Mergers and Acquisitions 8.3.3.1 Acquisition of Laboratorio Pfortner Cornealent SACIF 8.3.3.2 Valeant Acquisition of Bausch and Lomb 8.3.3.3 Acquisition of Technolas Perform Vision GmbH 8.3.3.4 Acquisition of Eyeonics 8.3.3.5 Bausch and Lomb Price Fixing in China 8.4 Johnson and Johnson Vision Care 8.4.1 Johnson and Johnson Vision Care Financial Performance, 2014 8.4.1.1 Johnson and Johnson Vision Care Financial Performance, 2013-2014 8.4.2 Product Line 8.4.3 Expansion of Manufacturing Facilities 8.4.4 Fined for Price Fixing Contact Lenses in China 8.5 Nidek 8.5.1 Nidek Financial Performance, 2012-2013 8.5.2 Product Line 8.5.2.1 Surgical Systems 8.5.2.2 Intraocular Lenses 8.5.2.3 Ophthalmic Lasers 8.5.2.4 Refractive Surgery Systems 8.5.2.5 Diagnostic Equipment 8.5.2.5.1 Retina and Glaucoma 8.5.2.5.2 Cornea and Cataract 8.6 Hoya Corporation 8.6.1 Hoya Financial Performance, 2013-2014 8.6.1.1 Hoya Financial Performance by Business Segment, 2014 8.6.2 IOL Product Line 8.7 STAAR Surgical (STAAR) 8.7.1 STAAR Surgical Financial Performance, 2012-2014 8.7.2 STAAR Revenue by Region, 2012-2014 8.7.3 STAAR Revenue by Segment, 2012-2014 8.7.4 Product Line 8.7.4.1 Intracollamer Lenses 8.7.4.2 Intraocular Lenses 8.8 Carl Zeiss AG Meditec 8.8.1 Carl Seizz Meditec Financial Performance, 2012-2014 8.8.1.1 Carl Zeiss Meditec Financial Performance by Business Segment, 2012-2014 8.8.1.2 Carl Zeiss Meditec Financial Performance by Region, 2014 8.8.2 Product Line 8.8.3 Mergers and Acquisitions 8.8.3.1 Acquisition of Aaren Scientific 8.8.3.2 Cooperation Agreement with Oraya Therapeutics Inc 8.9 TopCon 8.9.1 TopCon Financial Performance, 2012-2014 8.9.1.1 TopCon Financial Performance by Business Segment, 2014 8.9.2 Product Line 8.9.2.1 3D OCT-2000 Spectral Domain OCT 8.9.2.2 Other Major Products 8.9.3 Mergers and Acquisitions 8.9.3.1 Acquisition of Optimedica’s Retina and Glaucoma Business 8.10 Haag-Streit Holding AG 8.10.1 Product Line
9. Qualitative Analysis of the Ophthalmic Devices Market, 2015-2025 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market 9.1.1 Rivalry Among Competitors [High] 9.1.2 Threat of New Entrants [Medium] 9.1.3 Power of Suppliers [Low] 9.1.4 Power of Buyers [High] 9.1.5 Threat of Substitutes [High]
10. Interviews 10.1 Ellie Bai, Press Relations Officer, Taiwan Liposome Company (Taiwan) 10.1.1 Future of the Ophthalmic Therapeutics Delivery Market 10.1.2 Technological Advancement in Ophthalmic Devices 10.1.3 The Payment Environment 10.2 Martina Iniotri, Ophthalmic Services Specialist, JINS Eyewear (Japan) 10.2.1 Changes in the Vision Care Market 10.2.2 The Shape of the Contact Lens Market
11. Conclusions 11.1 The World Ophthalmic Devices Market, 2014-2015 11.2 Leading Ophthalmic Devices Submarkets 11.3 World Ophthalmic Devices Market Forecast, 2015-2025 11.4 Leading Segments of the Ophthalmic Devices Submarkets
List of Tables Table 2.1 Segments and Definitions of the Ophthalmic Market Table 2.2 ICD-10 Classification of Visual Impairment, 2010 Table 2.3 The US Classification of Medical Devices Table 2.4 The EU Classification of Medical Devices Table 2.5 The Japanese Classification of Medical Devices Table 3.1 The Global Medical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 3.2 Submarkets of the Ophthalmic Devices Market: Revenue ($bn), Market Share (%), 2014 Table 3.3 The Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%). . 2014-2025 Table 4.1 The Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.2 The Ophthalmic Vision Care Devices Market: Revenue ($bn), Market Share, (%) by Segment, 2014 Table 4.3 The Ophthalmic Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Segment, 2014-2025 Table 4.4 The Daily Disposable Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.5 The Other Contact Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.6 The Vision Care Market: Revenue ($bn), Market Share (%), by Region, 2014 Table 4.7 The Leading National Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.8 The US Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-. 2025 Table 4.9 The EU Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-. 2025 Table 4.10 The Chinese Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.11 The Japanese Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.12 The Russian Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.13 The Brazilian Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.14 The Indian Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.15 The South Korean Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.16 The Mexican Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.17 The Rest of the World Vision Care Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 4.18 Leading Silicone Hydrogel Contact Lenses Products in the Market, 2015 Table 4.19 SWOT Analysis of the Vision Care Devices Market, 2014-2025 Table 5.1 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), Market Share (%) by Segment, 2014 Table 5.2 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), CAGR (%) by Segment, 2014-2025 Table 5.3 The Autorefractor/Keratometer Market: Revenue ($bn), AGR (%), CAGR, (%), 2014-2025 Table 5.4 The Fundus Camera Market: Revenue ($bn), AGR (%), CAGR (%), 2014-. 2025 Table 5.5 The Slit Lamp Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.6 The OCT Machine Market: Revenue ($bn), AGR (%), CAGR (%), 2014-. 2025 Table 5.7 Leading Ophthalmic OCT Machines in the Market, 2015 Table 5.8 The Other Ophthalmic Diagnostics and Monitoring Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 5.9 SWOT Analysis of the Ophthalmic Diagnostics and Monitoring Devices . Market, 2014-205 Table 6.1 The Ophthalmic Surgical Devices Market: Revenue ($bn), Market Share, (%) by Segment, 2014 Table 6.2 The Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.3 The Intraocular Lenses Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.4 The Types of Premium IOLs on the Market, 2015 Table 6.5 The Ophthalmic Laser Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.6 The Phacoemulsification Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.7 The Phacoemulsification Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 6.9 SWOT Analysis of the Ophthalmic Surgical Devices Market 2014-2025 Table 7.1 The ophthalmic Devices Market: Revenue ($bn), Market Share (%), by . Region, 2014 Table 7.2 The Leading National Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.3 The Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by . Region, 2025 Table 7.4 The US Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.5 The European Ophthalmic Devices Market: Revenue ($bn), Market Share (%) by Country, 2014 Table 7.6 The European Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%) by Country, 2014-2025 Table 7.7 The German Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.8 The French Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.9 The Italian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.10 The Spanish Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.11 The UK Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.12 The Rest of Europe Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.13 The Japanese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.14 The Brazilian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.15 The Russian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.16 The Indian Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.17 The Chinese Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.18 The South Korean Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 7.19 The Mexican Ophthalmic Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Table 8.1 Alcon: Revenue ($m), AGR (%) by Segment, 2012-2014 Table 8.2 Alcon: Revenue Share (%) by Segment, 2013 & 2014 Table 8.3 Alcon Surgical Segment: Revenue ($m), AGR (%) by Subsegment, 2013-. 2014 Table 8.4 Alcon Vision Care Segment: Revenue ($m), AGR (%) by Subsegment, 2013-2014 Table 8.5 Abbott Medical Devices: Revenue ($m), AGR (%) by Segment, 2013-2014 Table 8.6 Abbott Medical Optics: Product Line, 2015 Table 8.7 Bausch and Lomb: Global Revenue, US Revenue and US Surgical and US Contact Lens Segment Revenues ($m), AGR (%), 2013-2014 Table 8.8 J&J Major Medical Devices: Revenue ($bn), Revenue Share (%) by . .Segment, 2014 Table 8.9 J&J Vision Care: Revenue ($m), AGR (%), 2011-2013 Table 8.10 J&J Vision Care: Product Line by Wear Time, 2015 Table 8.11 J&J Vision Care: Product Line by Type of Refractive Error, 2014 Table 8.12 Nidek: Revenue ($m), Constant Currency (CC) Revenue ($m), AGR (%), 2012-2013 Table 8.13 Hoya: Revenue ($m), Reported Revenue (¥m), AGR (%), 2014 Table 8.14 Hoya: Sales Percentage by Region (%) 2014 Table 8.15 Hoya: Life Care Revenue Breakdown: Healthcare and Medical ($m), 2014 Table 8.16 STAAR: Revenue ($m), AGR (%), CAGR (%), 2012-2014 Table 8.17 STAAR: Revenue ($m), Revenue Share (%) by Region, 2012-2014 Table 8.18 STAAR: Revenue ($m), AGR (%), CAGR (%) by Segment, 2012-2014 Table 8.19 STAAR: Product line Table 8.20 Carl Zeiss Meditec: Revenue ($m), AGR (%) and CAGR (%) 2012-2014 Table 8.21 Carl Zeiss Meditec: Revenue ($m), AGR (%) and CAGR (%) by Business .Unit, 2012-2014 Table 8.22 Carl Zeiss Meditec: Revenue ($m), Revenue Share (%) and Growth (%, Y/Y) by Region, 2014 Table 8.23 Carl Zeiss Meditec: Ophthalmic Product Line Table 8.24 TopCon: Revenue ($m), AGR (%) and CAGR (%), 2012-2014 Table 8.25 TopCon: Revenue ($m), Revenue Share (%) by Division, 2014 Table 8.26 TopCon: Revenue ($m), Revenue Share (%) by Location of Customers. 2014 Table 8.27 TopCon: Revenue ($m), Revenue Share (%) by Location of Company, 2014 Table 8.28 Haag-Streit: Medical Technology & Specialities
List of Figures Figure 1.1 Ophthalmic Devices: Overview of Submarkets and Devices Figure 2.1 Structure of the Human Eye Figure 2.2 Estimated Global Prevalence of Visual Impairment (millions of people), 2013 Figure 2.3 Estimated Global share of Visual Impairment Among Different Age. Groups, 2012 Figure 2.4 Global Causes of Visual Impairment (% of cases), 2013 Figure 3.1 The Global Medical Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 3.2 Submarkets of the Ophthalmic Devices Market: Revenue ($bn), 2014 Figure 3.3 Submarkets of the Ophthalmic Devices Market: Market Share (%), 2014 Figure 3.4 The Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.1 The Ophthalmic Vision Care Devices Market: Market Share (%) by Company, 2014 Figure 4.2 The Vision Care Devices Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025 Figure 4.3 The Ophthalmic Vision Care Devices Market: Revenue ($bn) by Segment, 2014 Figure 4.4 The Ophthalmic Vision Care Devices Market: Market Share (%) by Segment, 2014 Figure 4.5 The Ophthalmic Vision Care Devices Market: Revenue ($bn) by Segment, 2014-2025 Figure 4.6 The Daily Disposable Contact Lenses Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.7 The Other Contact Lenses Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.8 The Vision Care Market: Market Share (%) by Region, 2014 Figure 4.9 The US Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.10 The EU Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.11 The Chinese Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.12 The Japanese Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.13 The Russian Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.14 The Brazilian Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.15 The Indian Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.16 The South Korean Vision Care Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 4.17 The Mexican Vision Care Market: Revenue ($bn), AGR (%), 2014-2025 Figure 4.18 The Rest of World Vision Care Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 5.1 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn) by Segment, 2014 Figure 5.2 The Ophthalmic Diagnostics and Monitoring Devices Market Forecast: Market Share (%) by Segment, 2014 Figure 5.3 The Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), 2014-2025 Figure 5.4 The Autorefractor/Keratometer Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 5.5 The Fundus Camera Market: Revenue ($bn), AGR (%), 2014-2025 Figure 5.6 The Slit Lamp Market: Revenue ($bn), AGR (%), 2014-2025 Figure 5.7 The OCT Machine Market: Revenue ($bn), AGR (%), 2014-2025 Figure 5.8 The Other Ophthalmic Diagnostics and Monitoring Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.1 The Ophthalmic Surgical Devices Market: Revenue ($bn) by Segment, 2014 Figure 6.2 The Ophthalmic Surgical Devices Market: Market Share (%) by Segment, 2014 Figure 6.3 The Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.4 The Intraocular Lenses Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.5 The Ophthalmic Laser Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.6 The Phacoemulsification Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.7 The Ophthalmic Viscoelastic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.8 The Other Ophthalmic Surgical Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 6.9 Neurotech: Encapsulated Cell Technology Pipeline, 2015 Figure 6.10 Ocular Therapeutix: Punctum Plug Sustained Release Pipeline, 2015 Figure 7.1 The Ophthalmic Devices Market: Revenue ($bn) by Region, 2014 Figure 7.2 The Ophthalmic Devices Market: Market Share (%) by Region, 2014 Figure 7.3 The Ophthalmic Devices Market: Market Share (%) by Region, 2025 Figure 7.4 The US Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.5 The European Ophthalmic Devices Market: Revenue ($bn) by Country, 2014 Figure 7.6 The European Ophthalmic Devices Market: Market Share (%) by Country, 2014 Figure 7.7 The European Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.8 The German Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.9 The French Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 7.10 The Italian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 7.11 The Spanish Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.12 The UK Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 7.13 The Rest of EU Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.14 The Japanese Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.15 The Brazilian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.16 The Russian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.17 The Indian Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-. 2025 Figure 7.18 The Chinese Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.19 The South Korean Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 7.20 The Mexican Ophthalmic Devices Market: Revenue ($bn), AGR (%), 2014-2025 Figure 8.1 Alcon: Revenue Share (%) by Segment, 2014 Figure 8.2 Alcon Surgical Segment: Revenue Share (%) by Subsegment, 2014 Figure 8.3 Alcon Vision Care Segment: Revenue Share(%) by Subsegment, 2014 Figure 8.4 Abbott Medical Devices: Revenue Share (%) by Segment, 2014 Figure 8.5 Bausch and Lomb: Surgical and Contact Lens Revenues as Share of Total US Revenue ($m), 2014 Figure 8.6 Bausch and Lomb: US revenue as a Percentage of Total Global Revenue, (%), 2014 Figure 8.7 Bausch and Lomb: Surgical and Contact Lens US revenue as Percentage of US revenue, with US Revenue as a Percentage of Total Global Revenue, (%), 2014 Figure 8.8 J&J Major Medical Devices: Revenue Share (%) by Segment, 2014 Figure 8.9 Nidek: Share of Revenue by Segment (%), 2013 Figure 8.10 Nidek: Share of Revenue by Location (%), 2013 Figure 8.11 Hoya: Sales Percentage by Region (%), 2014 Figure 8.12 Hoya: Revenue Share (%) by Segment, 2014 Figure 8.13 STAAR: Revenue Share (%) by Region, 2014 Figure 8.14 STAAR: Revenue Share (%) by Product, 2014 Figure 8.15 Carl Zeiss Meditec: Revenue Share (%) by Business Unit, 2014 Figure 8.16 Carl Zeiss Meditec: Revenue Share (%) by Region, 2014 Figure 8.17 TopCon: Revenue Share (%) by Company, 2014 Figure 9.1 Porter’s Five Forces Analysis of the Ophthalmic Devices Market, 2015-. 2025 Figure 11.1 World Ophthalmic Devices Market: Revenue ($bn) by Submarket, 2014-. 2015 Figure 11.2 World Ophthalmic Devices Market: Revenue ($bn), 2014-2025
Abbott Medical Optics, Inc. Alcon (Novartis International AG) Alimera Sciences, Inc. Allergan/Actavis PLC Aquesys, Inc. Bausch and Lomb (Valeant Pharmaceuticals International, Inc.) Calhoun Vision, Inc. Canon, Inc. Carl Zeiss Meditec AG CooperVision Essilor International S.A. Forus Health Pvt. Ltd. Genentech, Inc. Glaukos Corporation Google, Inc. Heidelberg Engineering GmbH Hoya Corporation InSight Ivantis, Inc. Johnson & Johnson LENSAR, Inc. Marco Medennium, Inc. NeoMedix Corporation Neurotech Pharmaceuticals, Inc. Nidek Co., LTD. Nikon Corporation Novartis International AG NuLens Ocular Therapeutix, Inc. Optovue, Inc. Oraya Therapeutics International, Inc. OSI Pharmaceuticals, Inc. PowerVision, Inc. Regeneron Pharmaceuticals, Inc. Seiko Epson Corporation Sensimed SA Shanghai Weicon Optics Co., LTD. STAAR Surgical Co. Taiwan Liposome Company Ltd. TopCon Corporation Tomey Corporation Transcent Medical, Inc. Vision Solution Technologies, Inc. Valeant Pharmaceuticals International, Inc. WaveTec Vision (Novartis International AG)
Other Organisations Mentioned in this Report Food and Drug Administration (US) Japanese Ministry of Health, Labour, and Welfare (MHLW) Japanese Pharmaceutical and Medical Devices Agency (PMDA) Mexican National Institute of Statistics and Geography (INEGI) US Preventive Service Task Force (USPSTF) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Devices Market Forecast 2015-2025
Download sample pages
Complete the form below to download your free sample pages for Ophthalmic Devices Market Forecast 2015-2025
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.
Visiongain Publishes Antigen Skin Test Market Report to 2031
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.
Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.
Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031
The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
